E3 ubiquitin ligases as T cell anergy factors

Nature Immunology

Volumn 5, Issue 9, 2004, Pages 883-890

  Mueller, Daniel L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; GROWTH FACTOR; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE NEDD4;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL ACTIVITY; CLONAL ANERGY; ENZYME ACTIVITY; GENE TARGETING; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UBIQUITINATION; ANIMAL; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY;

ANIMALS; CLONAL ANERGY; HUMANS; MODELS, IMMUNOLOGICAL; SELF TOLERANCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UBIQUITIN-PROTEIN LIGASES;

EID: 4644285392     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1106     Document Type: Review

References (72)

1. Schwartz, R. H. T cell anergy. Annu. Rev. Immunol. 21, 305-334 (2003).
2. Janeway, C.A., Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
3. Mueller, D.L., Jenkins, M.K. & Schwartz, R.H. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7, 445-480 (1989).
4. Harding, F.A., McArthur, J.G., Gross, J.A., Raulet, D.H. & Allison, J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609 (1992).
5. Jenkins, M.K. & Schwartz, R.H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165, 302-319 (1987).
6. Quill, H. & Schwartz, R.H. Stimulation of normal inducer T cell clones with antigen presented by purified la molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J. Immunol. 138, 3704-3712 (1987).
7. Kearney, E.R., Pape, K.A., Loh, D,Y. & Jenkins, M.K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327-339 (1994).
8. + T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J. Immunol. 167, 2030-2009 (2001).
9. Perez, V.L. et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411-417 (1997).
10. Vanasek, T.L., Khoruts, A., Zell, T. & Mueller, D.L. Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness. J. Immunol, 167, 5636-5644 (2001).
11. Jenkins, M.K., Pardoll, D.M., Mizuguchi, J., Chused, T.M. & Schwartz, R.H. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. USA 84, 5409-5413 (1987).
12. Jain, J, et al. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365, 352-355 (1993).
13. Macian, F. et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719-731 (2002).
14. Telander, D.G., Malvey, E.-N. & Mueller, D.L. Evidence for repression of interleukin 2 gene activation in anergic T cells. J. Immunol. 162, 1460-1465 (1999).
15. + T cells. J. Immunol. 151, 2355-2367 (1993).
16. Gajewski, T.F., Qian, D., Fields, P. & Fitch, F.W. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc. Natl. Acad. Sci. USA 91, 38-42 (1994).
17. Mondino, A. et al. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells. J. Immunol. 157, 2048-2057 (1996).
18. + T cells. Science 271, 1272-1276 (1996).
19. + T cells. Science 271, 1276-1278 (1996).
20. 2-terminal kinase and mitogen-activated protein kinase signaling pathways. J. Exp. Med. 183, 2017-2023 (1996).
21. Kang, S.-M. et al. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257, 1134-1138 (1992).
22. Beverly, B., Kang, S.M., Lenardo, M.J. & Schwartz, R.H. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4, 661-671 (1992).
23. DeSilva, D.R., Urdahl, K.B. & Jenkins, M.K. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147, 3261-3267 (1991).
24. + T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160, 4719-4729 (1998).
25. Powell, J. D., Lerner, C.G. & Schwartz, R.H. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J. Immunol. 162, 2775-2784 (1999).
26. Weissman, A.M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell. Biol. 2, 169-178 (2001).
27. Thrower, J.S., Hoffman, L., Rechsteiner, M. & Pickart, C.M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102 (2000).
28. Haglund, K. et al. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat. Cell Biol. 5, 461-466 (2003).
29. VanDemark, A.P. & Hill, C.P. Structural basis of ubiquitylation. Curr. Opin. Struct. Biol. 12, 822-830 (2002).
30. Yaron, A. et al. Identification of the receptor component of the IκBα-ubiquitin ligase Nature 396, 590-594 (1998).
31. Hatakeyama, S. et al. Ubiquitin-dependent degradation of IκBα is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc. Natl. Acad. Sci. USA 96, 3859-3863 (1999).
32. Spencer, E., Jiang, J, & Chen, Z.J. Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β -TrCP. Genes Dev. 13, 284-294 (1999).
33. Winston, J.T. et al. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and beta-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13, 270-283 (1999).
34. Leulier, F. et al. The Drosophila immune system detects bacteria through specific peptidoglycan recognition. Nat. Immunol. 4, 478-484 (2003).
35. Leulier, F. et al. Directed expression of the HIV-1 accessory protein Vpu in Drosophila fat-body cells inhibits Toll-dependent immune responses. EMBO Rep. 4, 976-981 (2003).
36. Rutschmann, S. et al. The Rel protein DIF mediates the antifungal but not the antibacterial host defense in Drosophila. Immunity 12, 569-580 (2000).
37. Ryals, J. et al. The Arabidopsis NIM1 protein shows homology to the mammalian transcription factor inhibitor IκB. Plant Cell 9, 425-439 (1997).
38. Liu, Y., Schiff, M., Serino, G., Deng, X.W. & Dinesh-Kumar, S.P. Role of SCF ubiquitin-ligase and the COP9 signalosome in the N gene-mediated resistance response to Tobacco mosaic virus. Plant Cell 14, 1483-1496 (2002).
39. Liu, Y., Schiff, M., Marathe, R. & Dinesh-Kumar, S.P. Tobacco Rar1, EDS1 and NPR1/NIM1 like genes are required for N-mediated resistance to tobacco mosaic virus. Plant J. 30, 415-429 (2002).
40. Langdon, W.Y., Hartley, J.W., Klinken, S.P., Ruscetti, S.K. & Morse, H.C., 3rd. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl. Acad. Sci. USA 86, 1168-1172 (1989).
41. Blake, T.J., Shapiro, M., Morse, H.C., 3rd & Langdon, W.Y. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6, 653-657 (1991).
42. Boussiotis, V.A., Freeman, G.J., Berezovskaya, A., Barber, D.L. & Nadler, L.M. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 278, 124-128 (1997).
43. Dillon, T.J. et al. Ectopic B-Raf expression enhances extracellular signal-regulated kinase (ERK) signaling in T cells and prevents antigen-presenting cell-induced anergy. J. Biol. Chem. 278, 35940-35949 (2003).
44. Sebzda, E., Bracke, M., Tugal, T., Hogg, N. & Cantrell, D.A. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat. Immunol. 3, 251-258 (2002).
45. Joazeiro, C.A. et al. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286, 309-312 (1999).
46. Levkowitz, G. et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12, 3663-3674 (1998).
47. Wang, H.Y. et al. Cbl promotes ubiquitination of the T cell receptor ζ through an adaptor function of Zap-70. J. Biol. Chem. 276, 26004-26011 (2001).
48. Naramura, M. et al. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat. Immunol. 3, 1192-1199 (2002).
49. Murphy, M.A. et al. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol. Cell. Biol. 18, 4872-4882 (1998).
50. Naramura, M., Kole, H.K., Hu, R.J. & Gu, H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl. Acad. Sci. USA 95, 15547-15552 (1998).
51. Shao, Y., Elly, C. & Liu, Y.C. Negative regulation of Rap1 activation by the Cbl E3 ubiquitin ligase. EMBO Rep. 4, 425-431 (2003).
52. Heissmeyer, V. et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5, 255-265 (2004).
53. Zhang, J. et al. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J. Immunol. 169, 2236-2240 (2002).
54. Zhang, W. et al. Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b. J. Biol. Chem. 278, 23978-23983 (2003).
55. Chiang, Y.J. et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216-220 (2000).
56. Fang, D. & Liu, Y.C. Proteolysis-independent regulation of Pl3K by Cbl-b-mediated ubiquitination in T cells. Nat. Immunol. 2, 870-875 (2001).
57. Bachmaier, K. et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211-216 (2000).
58. Yokoi, N. et al. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat. Genet. 31, 391-394 (2002).
59. + T cells. Immunity 18, 535-547 (2003).
60. Soares, L. et al. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nat. Immunol. 5, 45-54 (2004).
61. Borchers, A.G. et al. The E3 ubiquitin ligase GREUL1 anteriorizes ectoderm during Xenopus development. Dev. Biol. 251, 395-408 (2002).
62. Angers, A., Ramjaun, A.R. & McPherson, P.S. The HECT domain ligase Itch ubiquitinates endophilin and localizes to the trans-Golgi network and endosomal system. J. Biol. Chem. 279, 11471-11479 (2004).
63. Qiu, L. et al. Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. J. Biol. Chem. 275, 35734-35737 (2000).
64. H2 differentiation. Nat. Immunol. 3, 281-287 (2002).
65. Imhof, M.O. & McDonnell, D.P. Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Mol. Cell. Biol. 16, 2594-2605 (1996).
66. + channel (ENaC) by ubiquitination. EMBOJ. 16, 6325-6336 (1997).
67. Lu, P.J., Zhou, X.Z., Shen, M. & Lu, K.P. Function of WW domains as phosphoserineor phosphothreonine-binding modules. Science 283, 1325-1328 (1999).
68. Magnifico, A. et al. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J. Biol. Chem. 278, 43169-43177 (2003).
69. Marchler-Bauer, A. et al. CDD: a curated Entrez database of conserved domain alignments. Nucleic Acids Res. 31, 383-387 (2003).
70. Grakoui, A. et al. The immunological synapse: a molecular machine controlling T cell activation. Science 285, 221-227 (1999).
71. Monks, C.R., Freiberg, B.A., Kupfer, H., Sciaky, N. & Kupfer, A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82-86 (1998).
72. Geer, L.Y., Domrachev, M., Lipman, D.J. & Bryant, S.H. CDART protein homology by domain architecture. Genome Res. 12, 1619-1623 (2002).